Forskningsartikel2008Vetenskapligt granskad
Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas
Hanson, J. M.; Mol, J. A.; Leegwater, P. A. J.; Bilodeau, S.; Drouin, J.; Meij, B. P.
Sammanfattning
Pituitary-dependent hyperadrenocorticism (PDH) in dogs is caused by a pituitary corticotroph adenoma. Although PDH is a common disorder in dogs, little is known about the underlying pathogenesis. In the pituitary glands of humans and mice, the proopiomelanocortin (POMC)-expressing cell lineages, the corticotrophs and melanotrophs, have a specific marker in common, the T-box transcription factor Tpit (Tbx19), which is obligate for POMC expression. Tpit also regulates the late differentiation of the corticotrophs and melanotrophs, and therefore may contribute to the pathogenesis of the corticotroph adenomas. The aim of this study was to perform an expression and mutation analysis of Tpit in the normal canine pituitary and in corticotroph adenomas. The distribution of the Tpit protein in the pituitary gland was studied with immunohistochemistry and the expression of the gene with RT-PCR. The coding region of Tpit cDNA from 14 dogs with PDH was screened for mutations. Tpit was expressed in corticotroph and melanotroph cells of the normal and adenomatous canine pituitary, and remained present in non-adenomatous corticotrophs of pituitaries from PDH dogs. No tumor-specific mutation in the Tpit cDNA from the corticotroph adenomas was found. However, a missense polymorphism in the highly conserved DNA-binding domain, the T-box, was discovered in one dog.It is concluded that Tpit can be used as a reliable marker for the corticotroph and melanotroph cells in the canine pituitary tissue and that mutations in the Tpit gene are unlikely to play a major role in the pathogenesis of canine corticotroph adenomas. (C) 2007 Elsevier Inc. All rights reserved.
Nyckelord
Cushing's disease; dog; pituitary-dependent hyperadrenocorticism; transcription factor; tumor; Tbx19
Publicerad i
Domestic Animal Endocrinology
2008, Volym: 34, nummer: 3, sidor: 217-222
UKÄ forskningsämne
Klinisk vetenskap
Publikationens identifierare
DOI: https://doi.org/10.1016/j.domaniend.2007.03.002
Permanent länk till denna sida (URI)
https://res.slu.se/id/publ/86228